Birdshot Chorioretinopathy: Resistant versus Responsive

Ocul Immunol Inflamm. 2023 Apr;31(3):477-482. doi: 10.1080/09273948.2022.2032193. Epub 2022 Mar 30.

Abstract

Purpose: To search findings that can explain the heterogeneity between Resistant and Responsive patients with birdshot chorioretinopathy.

Patients and methods: This was a retrospective observational case series on "Responsive" versus "Resistant" birdshot chorioretinopathy.

Results: One-hundred-eighty and Ninety-nine patients were included in the Responsive and Resistant groups respectively. Multivariate analysis of paraclinical variables at the first visit demonstrated that mean deviation (p = .04), pattern standard deviation (p < .001), optic nerve head leakage (p = .012), large vessel leakage and staining (p = .01), and macular small vessel leakage (p = .03) were statistically significantly different between the two groups; however, at the visit preceding successful therapy, only macular small vessel leakage (p = .01) was statistically significantly different between the two groups.

Conclusion: .Small vessel leakage in the macular area and/or optic nerve head leakage at the earliest visit might be risk factors for resistant birdshot chorioretinopathy.

Keywords: BSCR; Biologic response modifier; birdshot chorioretinopathy; corticosteroid; electroretinography; fluorescein angiography; immunomodulatory therapy; indocyanine green angiography; retinal vasculitis; short wavelength automated perimetry; visual field.

Publication types

  • Observational Study

MeSH terms

  • Birdshot Chorioretinopathy
  • Chorioretinitis* / diagnosis
  • Chorioretinitis* / drug therapy
  • Fluorescein Angiography
  • Humans
  • Retrospective Studies
  • Visual Acuity